Celecoxib-- the debate ranges on.
Gotlieb
D
D
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000191:economics / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control; D000068579:Celecoxib; D006801:Humans; D019458:Insurance Coverage; D007783:Lactones / Q000191:economics / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D011720:Pyrazoles; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012449:Safety; D013449:Sulfonamides / Q000191:economics / Q000627:therapeutic use*; D013450:Sulfones
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007783:Lactones; D011720:Pyrazoles; D013449:Sulfonamides; D013450:Sulfones; C116926:rofecoxib; D000068579:Celecoxib